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with a history of preeclampsia have a double risk of subsequent ischemic heart disease, stroke 
and thromboembolic events within the next 5-15 years after pregnancy. None of the 98 women 
after birth complicated with preeclampsia was not monitored, and so they developed 
complications.  
Conclusions. Preeclampsia is associated with a 4-fold increase in future incident heart failure 
and a 2-fold increased risk in coronary heart disease, stroke, and death because of coronary heart 
or cardiovascular disease. This important association can be used to screen for women with an 
increased risk to better target counselling on lifestyle modifications such as weight loss, exercise, 
and a healthier diet. 
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Introduction. Bacterial cells in the human body account for 1-3% of total body weight and are 
at least equal in number to human cells. Recent research has focused on understanding how the 
different bacterial communities in the body (eg, gut, respiratory, skin, and vaginal microbiomes) 
predispose to health and disease. For nearly 50 years, existing dogma has dictated that normal 
human endometrium is sacrosanct from microbial habitation in the absence of infection. 
However, while the vaginal microbiota has been investigated in depth, there is a paucity of 
consistent data regarding the existence of an endometrial microbiota and its possible impact in 
reproductive function. 
Aim of the study. To summarize the evidences derived from international studies on 
endometrial microbiome, its composition and potential influence in fertility and reproductive 
outcomes. 
Materials and methods. This study is a systematic review of data of the characteristics of 
endometrial microbiome in women with infertility and its association with the cause of 
infertility, conception rates and early pregnancy loss. Systematic literature searches of the 
electronic databases: Pubmed, EMBASE, the Cochrane library, MEDLINE, INTECH were 
performed up to February 2018 and included 44 studies. Studies were included if they reported 
on, at least, one of the following: characterization of endometrial microbiome in infertility – 30 
studies, association with conception – 18 studies, with early pregnancy loss – 15 studies. 
Results. The most represented genus was Lactobacillus (71.7% of identified bacteria); while 
Gardnerella (12.6%), Bifidobacterium (3.7%), Streptococcus (3.2%), and Prevotella (0.866%) 
were the other most common genera. Based on its composition, the microbiota in the 
endometrial fluid, comprising up to 191 operational taxonomic units, was defined as a 
Lactobacillus-dominated microbiota - >90% Lactobacillus spp., or a non-Lactobacillus-
dominated microbiota - <90% Lactobacillus spp. with >10% of other bacteria (Bacteroides, 
Prevotella, Fusobacterium, Atopobium vaginae, Mobiluncus curtisii). The presence of a non-
Lactobacillus-dominated microbiota in a receptive endometrium was associated with significant 
decreases in implantation [60.7% vs 23.1% (P=.02)], pregnancy [70.6% vs 33.3% (P=.03)], 
ongoing pregnancy [58.8% vs 13.3% (P=.02)], and live birth [58.8% vs. 6.7% (P=.002)] rates. 
Conclusions. The human microbiome has been termed the second genome, and its importance in 
reproductive success and failure has yet to be fully appreciated. The reviewed studies 
demonstrated the existence of an endometrial microbiota that is highly stable during the 
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acquisition of endometrial receptivity. However, pathological modification of its profile is 
associated with poor reproductive outcomes. 
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Introduction. Most doctors prefer to make a pelvic examination or an ultrasound before 
abortion to estimate gestational age, which increases the cost and time for medical abortion and 
can be provided only by certified obstetrician gynecologists. 
Aim of the study. To evaluate the certainty of women about their last menstrual period, to 
determine the gestational age and its correlation with the level of human chorionic gonadotropin, 
the safety of providing a medical abortion within less than 56 days without a prior pelvic 
examination and ultrasound. 
Materials and methods. We conducted a retrospective study in which the last menstrual period 
of 150 women was evaluated. We have also determined the levels of human chorionic 
gonadotropin with a semi-quantitative pregnancy test in five concentration ranges: 25 mIU/ml, 
100 mIU/ml, 500 mIU/ml, 2000 mIU/ml și 10000 mIU/ml and correlated the results with 
gestational age. Usually, the level of human chorionic gonadotropin at a gestational age of 8 
weeks is less than 10000 mIU/ml and at the age of 10-12 weeks is more than 10000 mIU/ml. We 
have assessed the possibility of excluding pelvic examination and ultrasound for evaluation of 
gestational age by determining the efficacy of medical abortion and the complications that 
appeared. 
Results. Out of 150 women seeking medical abortion, 149 (99.33%) were sure of their last 
menstrual period and only one patient, 0.67%, could appreciate the date of the unprotected 
sexual contact; 53.4% women had a gestational age of 4-5 weeks; 45.4% had 6-7 weeks and 
1.2% had a gestational age of 8 weeks. Out of women with a gestational age of 4-5 weeks, 
92.5% had the level of human chorionic gonadotropin of 500 mIU/ml; 5% had 100 mIU/ml; 
1.25% had a value of 100 mIU/l and 1.25% had the level of 2000 mIU/ml. In the group of 
women with a gestational age of 6-7 weeks, 95.6% had the level 500 mIU/ml; 3% - 2000 
mIU/ml, and 1.4% had the value of human chorionic gonadotropin of 100 mIU/ml. In women 
with 8 weeks of pregnancy only one woman, 50% had the level of human chorionic 
gonadotropin 500 mIU/ml and 50% had 2000 mIU/ml. No woman had a value of human 
chorionic gonadotropin over 10000 mIU/ml, which indicates that no woman had a gestational 
age over 10 weeks of pregnancy. The efficacy of medical abortion was 98.64 % and only 1.36% 
of women had complications, incomplete medical abortion and there were no suspicions that any 
woman had a gestational age over 9 weeks. 
Conclusions. Last menstrual period and the level of human chorionic gonadotropin are sufficient 
to determine the gestational age and to provide a safe medical abortion without pelvic 
examination and ultrasound. 
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